Castle biosciences to participate in upcoming investor conferences

Friendswood, texas, aug. 21, 2025 (globe newswire) -- castle biosciences, inc. (nasdaq: cstl), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at baird's 2025 global healthcare conference on wednesday, sept. 10, 2025, at 10:15 a.m.
CSTL Ratings Summary
CSTL Quant Ranking